Hydrea Action Mechanism
Hydrea prevents the progression of cancer through reducing the levels of deoxyribonucleotides in the body. Hydrea achieves this target by cleansing the free radicals of tyrosyl, which plays a crucial role in NDPs reduction.
The dosage of Hydrea to treat chronic myelocytic leukemia (CML) is a single dose which is given as 30 mg/ kg body weight per day. While the single dose of Hydrea to treat sickle cell anemia is 15 mg/kg body weight per day. It can be either with or without regard to food for its effective activity.
The potency and safety profile of Hydrea is responsible for its gaining popularity as one the best anti-cancer medication. Hydrea along with alleviating painful attacks in sickle-cell anemia also has the potential to work as anti-retroviral drug for curing AIDS.
Hydrea should be avoided if you are pregnant, breastfeeding or undergone any kind of vaccination procedure. Also individuals who are allergic to this medication and those with bone marrow disorders, liver or kidney diseases or with a cut caused due to injury or bruising should never plan to take Hydrea for treating cancer.
Hydrea Side effects
Hydrea normally do not show any grave side effects but some common and mild effects observed on its treatment include loss of appetite, Red coloration of face and headache.
Whereas the serious side effects of Hydrea reported in some extreme cases include seizures, sore throat, ulcers of skin, breathing problems, black or tarry stools, cough, numbness in your hands or feet and bloody urine. If any of these effects persist for longer duration then immediately consult your health care professional.